These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26113068)

  • 1. Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome.
    Varosanec M; Uher T; Horakova D; Hagemeier J; Bergsland N; Tyblova M; Seidl Z; Vaneckova M; Krasensky J; Dwyer MG; Havrdova E; Zivadinov R
    AJNR Am J Neuroradiol; 2015 Aug; 36(8):1457-64. PubMed ID: 26113068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI correlates of disability progression in patients with CIS over 48 months.
    Uher T; Horakova D; Bergsland N; Tyblova M; Ramasamy DP; Seidl Z; Vaneckova M; Krasensky J; Havrdova E; Zivadinov R
    Neuroimage Clin; 2014; 6():312-9. PubMed ID: 25379444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a.
    Uher T; Horakova D; Kalincik T; Bergsland N; Tyblova M; Ramasamy DP; Seidl Z; Vaneckova M; Krasensky J; Havrdova E; Zivadinov R
    Eur J Neurol; 2015 Jul; 22(7):1113-23. PubMed ID: 25904020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalamic atrophy is associated with development of clinically definite multiple sclerosis.
    Zivadinov R; Havrdová E; Bergsland N; Tyblova M; Hagemeier J; Seidl Z; Dwyer MG; Vaneckova M; Krasensky J; Carl E; Kalincik T; Horáková D
    Radiology; 2013 Sep; 268(3):831-41. PubMed ID: 23613615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spatio-temporal relationship between white matter lesion volume changes and brain atrophy in clinically isolated syndrome and early multiple sclerosis.
    Mattiesing RM; Gentile G; Brouwer I; van Schijndel RA; Uitdehaag BMJ; Twisk JWR; Kappos L; Freedman MS; Comi G; Jack D; De Stefano N; Barkhof F; Battaglini M; Vrenken H
    Neuroimage Clin; 2022; 36():103220. PubMed ID: 36274376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten-year follow-up of the 'minimal MRI lesion' subgroup from the original CHAMPS Multiple Sclerosis Prevention Trial.
    Simon JH; Kinkel RP; Kollman C; O'Connor P; Fisher E; You X; Hyde R;
    Mult Scler; 2015 Apr; 21(4):415-22. PubMed ID: 25344370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity.
    Bermel RA; Puli SR; Rudick RA; Weinstock-Guttman B; Fisher E; Munschauer FE; Bakshi R
    Arch Neurol; 2005 Sep; 62(9):1371-6. PubMed ID: 16157744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spatio-temporal relationship between concurrent lesion and brain atrophy changes in early multiple sclerosis: A post-hoc analysis of the REFLEXION study.
    Gentile G; Mattiesing RM; Brouwer I; van Schijndel RA; Uitdehaag BMJ; Twisk JWR; Kappos L; Freedman MS; Comi G; Jack D; Barkhof F; De Stefano N; Vrenken H; Battaglini M
    Neuroimage Clin; 2023; 38():103397. PubMed ID: 37086648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New and enlarging white matter lesions adjacent to the ventricle system and thalamic atrophy are independently associated with lateral ventricular enlargement in multiple sclerosis.
    Sinnecker T; Ruberte E; Schädelin S; Canova V; Amann M; Naegelin Y; Penner IK; Müller J; Kuhle J; Décard B; Derfuss T; Kappos L; Granziera C; Wuerfel J; Magon S; Yaldizli Ö
    J Neurol; 2020 Jan; 267(1):192-202. PubMed ID: 31612322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcortical grey matter volumes predict subsequent walking function in early multiple sclerosis.
    Nourbakhsh B; Azevedo C; Maghzi AH; Spain R; Pelletier D; Waubant E
    J Neurol Sci; 2016 Jul; 366():229-233. PubMed ID: 27288812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study.
    Horakova D; Cox JL; Havrdova E; Hussein S; Dolezal O; Cookfair D; Dwyer MG; Seidl Z; Bergsland N; Vaneckova M; Zivadinov R
    J Neurol Neurosurg Psychiatry; 2008 Apr; 79(4):407-14. PubMed ID: 17550987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event.
    Weinstock-Guttman B; Zivadinov R; Horakova D; Havrdova E; Qu J; Shyh G; Lakota E; O'Connor K; Badgett D; Tamaño-Blanco M; Tyblova M; Hussein S; Bergsland N; Willis L; Krasensky J; Vaneckova M; Seidl Z; Ramanathan M
    J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1186-91. PubMed ID: 23595944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years.
    Zivadinov R; Bergsland N; Dolezal O; Hussein S; Seidl Z; Dwyer MG; Vaneckova M; Krasensky J; Potts JA; Kalincik T; Havrdová E; Horáková D
    AJNR Am J Neuroradiol; 2013 Oct; 34(10):1931-9. PubMed ID: 23578679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis.
    Bergsland N; Horakova D; Dwyer MG; Dolezal O; Seidl ZK; Vaneckova M; Krasensky J; Havrdova E; Zivadinov R
    AJNR Am J Neuroradiol; 2012 Sep; 33(8):1573-8. PubMed ID: 22499842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrophied Brain Lesion Volume: A New Imaging Biomarker in Multiple Sclerosis.
    Dwyer MG; Bergsland N; Ramasamy DP; Jakimovski D; Weinstock-Guttman B; Zivadinov R
    J Neuroimaging; 2018 Sep; 28(5):490-495. PubMed ID: 29856910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal associations between brain structural changes and fatigue in early MS.
    Nourbakhsh B; Azevedo C; Nunan-Saah J; Maghzi AH; Spain R; Pelletier D; Waubant E
    Mult Scler Relat Disord; 2016 Jan; 5():29-33. PubMed ID: 26856940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome.
    Uher T; Blahova-Dusankova J; Horakova D; Bergsland N; Tyblova M; Benedict RH; Kalincik T; Ramasamy DP; Seidl Z; Hagermeier J; Vaneckova M; Krasensky J; Havrdova E; Zivadinov R
    J Neurol; 2014 Sep; 261(9):1735-44. PubMed ID: 24952618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.
    Ramasamy DP; Benedict RH; Cox JL; Fritz D; Abdelrahman N; Hussein S; Minagar A; Dwyer MG; Zivadinov R
    J Neurol Sci; 2009 Jul; 282(1-2):47-54. PubMed ID: 19201003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
    Deppe M; Marinell J; Krämer J; Duning T; Ruck T; Simon OJ; Zipp F; Wiendl H; Meuth SG
    Neuroimage Clin; 2014; 6():475-87. PubMed ID: 25610761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Serial 10-Year Follow-Up Study of Atrophied Brain Lesion Volume and Disability Progression in Patients with Relapsing-Remitting MS.
    Zivadinov R; Horakova D; Bergsland N; Hagemeier J; Ramasamy DP; Uher T; Vaneckova M; Havrdova E; Dwyer MG
    AJNR Am J Neuroradiol; 2019 Mar; 40(3):446-452. PubMed ID: 30819766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.